Deployment of COVID-19 vaccines

COVID-19 Vaccine Development Tools Market Research Report 2021 - ResearchAndMarkets.com

Retrieved on:

Wednesday, July 28, 2021

Biotechnology, General Health, Infectious diseases, Health, Pharmaceutical, World Health Organization, Medical research, COVAX, Medicine, Health sciences, COVID-19 vaccine, Articles, Deployment of COVID-19 vaccines, COVID-19 vaccination in the Philippines

The "COVID-19 Vaccine Development Tools Market Size, Share & Trends Analysis Report by Technology, by Application (Vaccine Process Development, Vaccine Research), by End Use (CROs, Pharma & Biopharma Companies), and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "COVID-19 Vaccine Development Tools Market Size, Share & Trends Analysis Report by Technology, by Application (Vaccine Process Development, Vaccine Research), by End Use (CROs, Pharma & Biopharma Companies), and Segment Forecasts, 2021 - 2028" report has been added to ResearchAndMarkets.com's offering.
The market is expected to expand at a CAGR of 8.6% from 2021 to 2028.
Research professionals across the globe, are rapidly persuading the identification and development of viable candidates to develop COVID-19 immunization shots.
The tools are also pooled under the umbrella mechanism, namely, the COVAX Facility to ensure effective procurement as well as equitable access to, COVID-19 vaccination and development tools.

BioNTech Provides Update on Plans to Develop Sustainable Solutions to Address Infectious Diseases on the African Continent

Retrieved on:

Monday, July 26, 2021

BioNTech, Health sciences, Medicine, Medical research, COVID-19, COVID-19 vaccines, Clinical trials, RNA vaccines, Pfizer–BioNTech COVID-19 vaccine, Vaccine, Africa Centres for Disease Control and Prevention, Deployment of COVID-19 vaccines

The second objective is the development of sustainable vaccine production and supply solutions on the African continent.

Key Points:

The second objective is the development of sustainable vaccine production and supply solutions on the African continent.
BioNTech is exploring possibilities to set up state-of-the-art mRNA manufacturing facilities, either with partners or on its own.
The facilities are expected to manufacture various mRNA-based vaccines upon approval to ensure sustainable supply operations.
BioNTech plans to co-locate its African manufacturing capabilities with the technology transfer hubs under development by the WHO, in alignment with the African manufacturing strategy created by the Africa CDC.

Expert Available to Comment on Potential COVID-19 Booster Shots, Global Vaccination Efforts

Retrieved on:

Tuesday, July 20, 2021

Medicine, Health sciences, COVID-19 vaccines, COVID-19, Clinical trials, Medical research, Vaccines, COVID-19 vaccine, Vaccine, Vaccination, COVID-19 vaccination in the Philippines, Deployment of COVID-19 vaccines

Vaccine makers have announced plans to seek authorization for supplementary doses, yet many countries around the world still do not have vaccines available for all and their populations are at a greater risk of infection and disease.

Key Points:

Vaccine makers have announced plans to seek authorization for supplementary doses, yet many countries around the world still do not have vaccines available for all and their populations are at a greater risk of infection and disease.
Dr. Reithinger has participated in several media interviews throughout the COVID-19 pandemic to provide insight on global vaccine distribution planning and vaccine diplomacy.
He can speak to the benefits and risks of prioritizing a third dose of the COVID-19 vaccine in the US vs. ramping up vaccination efforts in other countries across the globe.
Dr. Reithinger can also comment on the importance of working together with low-and-middle-income countries to rollout COVID-19 vaccines, while simultaneously prioritizing programs to eliminate other diseases.

Tidal Basin Partnered With The State Of Florida -- Enabling Equitable Access To COVID Vaccines Through Appointment Hotlines And On-Site Support At More Than 150 Points Of Distribution Throughout The State

Retrieved on:

Thursday, July 15, 2021

Medical specialties, Vaccination, Vaccine, Virology, Life sciences, Medicine, Vaccines, Medical research, Deployment of COVID-19 vaccines

To meet its mission, Tidal Basin deployed more than 160 field staff to support the state and counties with managing the vaccine distribution end-to-end process.

Key Points:

To meet its mission, Tidal Basin deployed more than 160 field staff to support the state and counties with managing the vaccine distribution end-to-end process.
The call center was launched within 72 hours, initially deploying 100 call agents, but quickly ramped up to 6,000 staff at the peak.
"Our organizational capabilities are helping Florida provide their residents with greater access to vaccines."
"Tidal Basin has improved vaccine distribution by providing state and county officials with expanded transparency into vaccination data."

SINOVAC Enters Into Agreement to Supply CoronaVac® to COVAX

Retrieved on:

Monday, July 12, 2021

According to the APA, SINOVAC will supply 50 million doses of CoronaVac by the end of September of 2021.

Key Points:

According to the APA, SINOVAC will supply 50 million doses of CoronaVac by the end of September of 2021.
I welcome todays agreement, which will make doses immediately available to COVAX participants, said Dr. Seth Berkley, CEO of Gavi.
Mr. Weidong Yin, Chairman, President, and CEO of SINOVAC said, Our mission at Sinovac is to supply vaccines in an effort to eliminate human disease.
We appreciate the efforts from international organizations, including WHO and COVAX partners, to accelerate the efforts of disease prevention.

Worldwide Vaccine Delivery Devices Industry to 2026 - Featuring BD, Corium and Smiths Medical Among Others - ResearchAndMarkets.com

Retrieved on:

Tuesday, July 6, 2021

Health, General Health, Medical specialties, Medicine, Vaccination, Vaccine, Virology, Health sciences, Vaccines, Medical research, Influenza vaccine, Deployment of COVID-19 vaccines

This report provides a detailed description of vaccine delivery devices and the latest technologies in the market.

Key Points:

This report provides a detailed description of vaccine delivery devices and the latest technologies in the market.
The report includes market estimates for different types of vaccine delivery devices.
Based on end-users, the vaccine delivery device market is segmented into hospitals, clinics and other end-users (vaccination centers, tertiary care centers, etc.).
This report also discusses competition in the global vaccine delivery device market and the key players' strategies and performances.

Press release - Parliament calls for temporary COVID-19 vaccine patent waiver

Retrieved on:

Thursday, June 10, 2021

World Health Organization, Medicine, COVAX, Medical specialties, Health sciences, Vaccine, Medical research, Deployment of COVID-19 vaccines

MEPs also point to the threat that an indefinite TRIPS Agreement waiver would pose to research finance, in particular for researchers, investors, developers and clinical trials.

Key Points:

MEPs also point to the threat that an indefinite TRIPS Agreement waiver would pose to research finance, in particular for researchers, investors, developers and clinical trials.
The US and the UK, for their part, should immediately abolish their export ban on vaccines and raw materials, they say.
Another important vehicle to provide vaccines to low income economies is the global vaccine distribution mechanism COVAX to which Parliament encourages contributions.
At a debate preceding the adoption of the resolution, several political groups argued in favour of lifting the intellectual property rights protections on COVID-19 related vaccines.

Rite Aid Extends Vaccinating Hours Every Friday in June to Increase COVID-19 Vaccine Accessibility

Retrieved on:

Thursday, June 10, 2021

Women, Pharmaceutical, MEN, General Health, Health, Family, Infectious diseases, Consumer, Biotechnology, Vaccination, Deployment of COVID-19 vaccines, COVID-19 vaccination in Bulgaria

Rite Aid will launch Night Shots Friday, June 11, and extend vaccinating hours until midnight at more than 200 locations.

Key Points:

Rite Aid will launch Night Shots Friday, June 11, and extend vaccinating hours until midnight at more than 200 locations.
On the same dates, 27 Rite Aid locations will administer COVID-19 vaccines for the full 24hour day.
Offering extended hours for COVID-19 vaccine availability helps to ensure everyone, especially individuals with less flexible work hours, has the opportunity to get vaccinated.
Rite Aid is committed to expanding access to essential COVID-19 services to help bring an end to the pandemic.

Projects selected under the Vaccine Community Innovation Challenge to help promote vaccine confidence

Retrieved on:

Monday, June 7, 2021

Medicine, Health, Medical research, COVID-19 vaccine, Vaccine, Vaccine adverse event, Deployment of COVID-19 vaccines

As COVID-19 vaccines roll out across the country, the Public Health Agency of Canada is supporting community-driven information initiatives through its Vaccine Community Innovation Challenge.

Key Points:

As COVID-19 vaccines roll out across the country, the Public Health Agency of Canada is supporting community-driven information initiatives through its Vaccine Community Innovation Challenge.
Through the Vaccine Community Innovation Challenge, the Government of Canada is engaging directly with communities to increase confidence in vaccination.
The Vaccine Community Innovation Challenge is one of several programs by the Government of Canada to work with community partners and stakeholders to increase vaccine confidence and address barriers to getting vaccinated.
The Vaccine Community Innovation Challenge gives communities resources to spread the word about COVID-19 vaccines and increase vaccine confidence through creative, community-driven and culturally appropriate means.

Global Coronavirus Vaccine Market Report 2020: Size, Share, Outlook, and Opportunity Analysis, 2019-2027 - ResearchAndMarkets.com

Retrieved on:

Wednesday, June 2, 2021

Infectious diseases, Pharmaceutical, Health, Medical specialties, COVID-19 vaccines, Clinical trials, Medicine, COVID-19, Vaccination, Vaccine, Virology, Pfizer–BioNTech COVID-19 vaccine, Operation Warp Speed, Deployment of COVID-19 vaccines

The "Corona Virus Vaccine Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.

Key Points:

The "Corona Virus Vaccine Market - Size, Share, Outlook, and Opportunity Analysis, 2019 - 2027" report has been added to ResearchAndMarkets.com's offering.
The increasing adoption of inorganic growth strategies such as partnerships and collaborations by key players, as well as by the government to increase the production and distribution of COVID-19 vaccines are expected to propel the market growth during the forecast period.
For instance, on August 14, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DoD) entered into an agreement with Moderna, Inc., to manufacture and deliver 100 million doses of COVID-19 vaccines produced by the company in the U.S by 2021.
Similarly, on October 16, 2020, the U.S. Department of Health and Human Services (HHS) and Department of Defense (DOD) entered into an agreement with CVS and Walgreens to provide and administer COVID-19 vaccines to residents of long-term care facilities (LTCF) in the U.S. with no out-of-pocket costs.